Receptor-based pharmacophore tool for design and development of next-generation drugs

No abstract is available for this paper.

• Publication year

  2013

• Venue

  International Journal of Bioinformatics Research and Applications

• Publication date

  2013-08-01

• Fields of study

  Medicine, Chemistry, Computer Science

• Identifiers
  DOI 10.1504/IJBRA.2013.056076PMID 24001724
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacophore and QSAR modeling of estrogen receptor beta ligands and subsequent validation and in silico search for new hits.

  2010cited by this paper
• Structure-based discovery of antibacterial drugs

  2010cited by this paper
• Three-dimensional pharmacophore methods in drug discovery.

  2010cited by this paper
• Alignment-Free Ultra-High-Throughput Comparison of Druggable Protein-Ligand Binding Sites

  2010cited by this paper
• 3D QSAR pharmacophore based virtual screening and molecular docking for identification of potential HSP90 inhibitors.

  2010cited by this paper
• Molecular modelling and docking studies on heat shock protein 90 (Hsp90) inhibitors

  2010cited by this paper
• HDAPD: a web tool for searching the disease-associated protein structures

  2010cited by this paper
• Design, synthesis, and interaction study of quinazoline-2(1H)-thione derivatives as novel potential Bcl-xL inhibitors.

  2010cited by this paper
• 3D Protein structure prediction with genetic tabu search algorithm

  2010cited by this paper
• A collaborative database and computational models for tuberculosis drug discovery.

  2010cited by this paper
• Contributions of computational chemistry and biophysical techniques to fragment-based drug discovery.

  2010cited by this paper
• SKPDB: a structural database of shikimate pathway enzymes

  2010cited by this paper
• Visualization of macromolecular structures

  2010cited by this paper
• Integrating molecular diagnostics into anticancer drug discovery

  2010cited by this paper
• 3D-Pharmacophore mapping of thymidine-based inhibitors of TMPK as potential antituberculosis agents

  2010cited by this paper
• Molecular shape technologies in drug discovery: methods and applications.

  2010cited by this paper
• Pharmacophore Screening of the Protein Data Bank for Specific Binding Site Chemistry

  2010cited by this paper
• Pharmacophore Modeling, Quantitative Structure-Activity Relationship Analysis, and Shape-Complemented in Silico Screening Allow Access to Novel Influenza Neuraminidase Inhibitors

  2009cited by this paper
• A Novel Approach for Efficient Pharmacophore-based Virtual Screening: Method and Applications

  2009cited by this paper
• Pharmacophore-based virtual screening versus docking-based virtual screening: a benchmark comparison against eight targets

  2009cited by this paper
• HotSpot Wizard: a web server for identification of hot spots in protein engineering

  2009cited by this paper
• Ligand-based and structure-based virtual screening to identify carbonic anhydrase IX inhibitors.

  2009cited by this paper
• Common Pharmacophore Identification Using Frequent Clique Detection Algorithm

  2009cited by this paper
• Characterization of Activity Landscapes Using 2D and 3D Similarity Methods: Consensus Activity Cliffs

  2009cited by this paper
• Knowledge based identification of MAO-B selective inhibitors using pharmacophore and structure based virtual screening models.

  2009cited by this paper
• Enhanced Semantic Interoperability by Profiling Health Informatics Standards

  2009cited by this paper
• Pharmacophore‐Based Discovery of Small‐Molecule Inhibitors of Protein–Protein Interactions between HIV‐1 Integrase and Cellular Cofactor LEDGF/p75

  2009cited by this paper
• 3D-pharmacophere models for CC chemokine receptor 1 antagonists.

  2009cited by this paper
• 3D-pharmacophore model for RXR(gamma) agonists.

  2009cited by this paper
• Scaffold Hopping in Drug Discovery Using Inductive Logic Programming

  2008cited by this paper
• PharmaGist: a webserver for ligand-based pharmacophore detection

  2008cited by this paper
• Structure‐based approach to pharmacophore identification, in silico screening, and three‐dimensional quantitative structure–activity relationship studies for inhibitors of Trypanosoma cruzi dihydrofolate reductase function

  2008cited by this paper
• A self‐organizing algorithm for molecular alignment and pharmacophore development

  2008cited by this paper
• Pharmacophore modeling and virtual screening for designing potential PLK1 inhibitors.

  2008cited by this paper
• Virtual Screening of Cathepsin K Inhibitors Using Docking and Pharmacophore Models

  2008cited by this paper
• Pharmacophore modeling and virtual screening studies to design some potential histone deacetylase inhibitors as new leads.

  2008cited by this paper
• Modeling and informatics in designing anti-diabetic agents.

  2007cited by this paper
• Pharmacophore modeling in drug discovery and development: an overview.

  2007cited by this paper
• Significance Analysis and Multiple Pharmacophore Models for Differentiating P-Glycoprotein Substrates

  2007cited by this paper
• Efficient overlay of small organic molecules using 3D pharmacophores

  2007cited by this paper
• Pharmacophore modeling for protein tyrosine phosphatase 1B inhibitors

  2007cited by this paper
• Fast and Efficient in Silico 3D Screening: Toward Maximum Computational Efficiency of Pharmacophore-Based and Shape-Based Approaches

  2007cited by this paper
• Flexible 3D pharmacophores as descriptors of dynamic biological space.

  2007cited by this paper
• Computational screening of inhibitors for HIV-1 integrase using a receptor based pharmacophore model

  2006cited by this paper
• Utilizing peptide structures as keys for unlocking challenging targets.

  2006cited by this paper
• GBPM: GRID-based pharmacophore model: concept and application studies to protein-protein recognition

  2006cited by this paper
• Structure-Based Pharmacophore Design and Virtual Screening for Novel Angiotensin Converting Enzyme 2 Inhibitors

  2006cited by this paper
• Dynamic receptor-based pharmacophore model development and its application in designing novel HIV-1 integrase inhibitors.

  2005cited by this paper
• Active Site Driven Ligand Design: an Evolutionary Approach

  2005cited by this paper
• Predicting molecular interactions in silico: I. A guide to pharmacophore identification and its applications to drug design.

  2004cited by this paper
• Design of non-nucleoside inhibitors of HIV-1 reverse transcriptase with improved drug resistance properties. 1.

  2004cited by this paper
• 1H NMR relaxometric characterization of bovine lactoferrin.

  2004cited by this paper
• Strategy of computer-aided drug design.

  2003cited by this paper
• Structure-based inhibitor design targeting HIV-1 integrase.

  2002cited by this paper
• History and evolution of the pharmacophore concept in computer-aided drug design.

  2002cited by this paper
• A Web-Based 3D-Database Pharmacophore Searching Tool for Drug Discovery

  2002cited by this paper
• THE FUNDAMENTALS OF PHARMACOPHORE MODELING IN COMBINATORIAL CHEMISTRY*

  2001cited by this paper
• Pharmacophore perception, development, and use in drug design

  2000cited by this paper
• Molecular classification of cancer: class discovery and class prediction by gene expression monitoring.

  1999cited by this paper
• Pharmacophores in drug design and discovery.

  1998cited by this paper
• Three-dimensional structure of diferric bovine lactoferrin at 2.8 A resolution.

  1997cited by this paper
• Data Mining: An Overview from a Database Perspective

  1996cited by this paper
• The structural basis of aspirin activity inferred from the crystal structure of inactivated prostaglandin H2 synthase

  1995cited by this paper
• Multinuclear, multidimensional NMR studies of Anabaena 7120 heterocyst ferredoxin. Sequence-specific resonance assignments and secondary structure of the oxidized form in solution.

  1994cited by this paper
• Multinuclear magnetic resonance studies of the 2Fe.cntdot.2S* ferredoxin from Anabaena species strain PCC 7120. 1. Sequence-specific hydrogen-1 resonance assignments and secondary structure in solution of the oxidized form

  1990cited by this paper
• Thermodynamic analysis of the drug-receptor interaction.

  1989cited by this paper
• Using CONCORD to construct a large database of three-dimensional coordinates from connection tables

  1989cited by this paper

• Ensemble-Based Virtual Screening Led to the Discovery of Novel Lead Molecules as Potential NMBAs

  2024cites this paper
• Virtual Screening-Based Drug Development for the Treatment of Nervous System Diseases

  2022cites this paper
• Provenance of Computers in Pharmacy

  2015cites this paper
• APPLICATIONS OF BIOINFORMATICS IN PHARMACEUTICAL PRODUCT DESIGNING: A REVIEW

  2015cites this paper